Dr. Josep Dalmau is an international leader in the study of neurology and psychiatry. In the last 7 years he has identified a total of eight autoimmune brain diseases. His group research is focused on a type of diseases related to autoimmunity, cancer and synaptic proteins. They have described novel syndromes and associated immune-mechanisms, isolated the target antigens, and developed diagnostic tests some of which are currently used around the world.
His group has discovered a new category of autoimmune diseases responsible for changes in memory, behavior, cognition and that can cause psychosis. The results of their studies have had a major impact in the field of neuroscience and multiple medical disciplines because they offer a connection between immunological processes and neural functions related to memory, behavior, psychosis, epilepsy and neuronal degeneration.
Dr. Dalmau has published 323 original articles in scientific journals like The New England Journal of Medicine, Lancet Neurology, Cell, Annals of Neurology and Neurology, and his papers are among the most cited his field. He has received numerous awards, including the Developmental Clinical Oncology Career Award (American Cancer Society), Neuroscience of Brain Disorders Award (McKnight Foundation), Neuroscience Research Program Award (Charles A. Dana Foundation), George W. Jacoby Award (American Neurological Association) Career Award (European Society of Neuroimmunology) Editors of Brain Award (Association of British neurologist) and Frontiers in Clinical Neuroscience Award (American Academy of Neurology). He is associate editor of the journal of the American Academy of Neurology, "Neurology", and editor of the magazine of the same academy, "Neurology and Neuroimmunology Neuroinflammation". His current research is supported by two NIH institutions (NINDS and NIMH) and the Instituto Carlos III, the National French Institute of Health and Research and the Cellex Foundation.
New members of the NAM are elected by current active members through a selective process that recognizes individuals who have made major contributions to the advancement of the medical sciences, healthcare, and public health. The newly elected members raise NAM’s total active membership to 1,826 and the number of international members to 137.